[{"Assets_0_Q1_USD":225408000.0,"CommonStockSharesOutstanding_0_Q1_shares":33634673.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-24854000.0,"NetIncomeLoss_1_Q1_USD":-25787000.0,"StockholdersEquity_0_Q1_USD":84116000.0,"Ticker":"AERI","CIK":"1337553","name":"AERIE PHARMACEUTICALS INC","OfficialName":"Aerie Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"408427417.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20170503"}]